Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 known ✓ | P31645 | 4/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17880592 | 0.94 | KCNH2 (0.46) | KCNH2SLC6A4SLC6A2KDM4EALDH1A1 | |
| SCHEMBL31543759 | 0.94 | KCNH2 (0.46) | KCNH2SLC6A4SLC6A2KDM4EALDH1A1 | |
| Oxalic Acid SCHEMBL31054153 | 0.91 | SLC6A9 (0.44) | SLC6A4KDM4EALDH1A1SLC6A9HRH3 | |
| Oxalic Acid SCHEMBL19742808 | 0.91 | SLC6A9 (0.44) | SLC6A4KDM4EALDH1A1SLC6A9HRH3 | |
| Oxalic Acid SCHEMBL19742813 | 0.89 | KDM4E (0.41) | SLC6A4SLC6A2KDM4ESLC6A9AOC3 | |
| Oxalic Acid SCHEMBL19742736 | 0.89 | AOC3 (0.38) | KCNH2SLC6A4KDM4EALDH1A1SLC6A9 | |
| Oxalic Acid SCHEMBL19742819 | 0.89 | UTS2R (0.42) | KCNH2SLC6A4SLC6A2KDM4EALDH1A1 | |
| Oxalic Acid SCHEMBL19742820 | 0.87 | SLC6A9 (0.40) | SLC6A4SLC6A2SLC6A9HRH3 | |
| Oxalic Acid SCHEMBL19742826 | 0.86 | SLC6A4 (0.54) | KCNH2SLC6A4SLC6A2HRH3 | |
| Oxalic Acid SCHEMBL19742815 | 0.86 | SLC6A9 (0.43) | SLC6A4SLC6A2KDM4EALDH1A1SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10093644-B2 | 3-[(Benzo[D][1,3]dioxolan-4-yl)-oxy]-3-arylpropylamine type compounds and applications thereof | NHWA PHARMA. CORPORATION (CN) | 2018-10-09 | — | — | US | disclosed |
| US-20170369466-A1 | 3-[(BENZO[D][1,3]DIOXOLAN-4-YL)-OXY]-3-ARYLPROPYLAMINE TYPE COMPOUNDS AND APPLICATIONS THEREOF | NHWA PHARMA. CORPORATION (CN) | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10093644-B2 | 3-[(Benzo[D][1,3]dioxolan-4-yl)-oxy]-3-arylpropylamine type compounds and applications thereof | TPH1, MAOA, MAOB | SLC6A4 7/4885KCNH2 449/4885SLC6A2 20/4885 |
| US-20170369466-A1 | 3-[(BENZO[D][1,3]DIOXOLAN-4-YL)-OXY]-3-ARYLPROPYLAMINE TYPE COMPOUNDS AND APPLICATIONS THEREOF | TPH1, MAOA, MAOB | SLC6A4 7/4885KCNH2 449/4885SLC6A2 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.